Here, by employing PIEZO1 agonist Yoda1 and siRNA technology, we demonstrate that PIEZO1 is highly expressed in human synovial sarcoma SW982 cells and its knockdown affects the cell-viability. The gene discussed is PIEZO1; the disease is synovial sarcoma.